Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 0316684-0000 | None | drug-path |
| Asthma | R-HSA-444620 | map05310 | 0316684-0000 | None | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | 0316684-0000 | None | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | 0316684-0000 | None | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | 0316684-0000 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-972 | None | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | Prestwick-972 | None | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | Prestwick-972 | None | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | Prestwick-972 | None | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | Prestwick-972 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | lincomycin | 3000540 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | lincomycin | 3000540 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | lincomycin | 3000540 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | lincomycin | 3000540 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | lincomycin | 3000540 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | lincomycin | 3000540 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | lincomycin | 3000540 | drug-path |
| Asthma | R-HSA-444620 | map05310 | lincomycin | 3000540 | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | lincomycin | 3000540 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | lincomycin | 3000540 | drug-path |